Kilter Group’s Chemed CHE Stock Holding History

Kilter Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33K	Buy	5 +2	+67%	+$841	﹤0.01%	964
2026 Q1	$1.13K	Hold	3	–	–	﹤0.01%	1193
2025 Q4	$1.28K	Buy	+3	New	+$1.31K	﹤0.01%	968

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Kilter Group's CHE Position: Q2 2026 in Review

Kilter Group increased its Chemed (CHE) stake by 67% in Q2 2026, buying an estimated $841 and bringing the position to 5 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Kilter Group first reported a position in CHE in Q4 2025 and has held it in 3 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Kilter Group held 5 shares of Chemed worth $2.33K as of Q2 2026.
Kilter Group bought 2 Chemed shares in Q2 2026, an estimated $841.
Chemed made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #964 holding.
Kilter Group first reported a position in Chemed in Q4 2025 and has held it in 3 quarters since.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.